Simplex Trading
BCYC

Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History

Simplex Trading’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Buy
29,600
+28,800
+3,600% +$165K ﹤0.01% 4727
2025
Q4 		$5.66K Sell
800
-9,500
-92% -$70K ﹤0.01% 7362
2025
Q3 		$79K Buy
10,300
+8,800
+587% +$66.4K ﹤0.01% 6008
2025
Q2 		$10K Sell
1,500
-800
-35% -$6.37K ﹤0.01% 7294
2025
Q1 		$19K Hold
2,300
– – ﹤0.01% 6605
2024
Q4 		$32K Sell
2,300
-3,000
-57% -$64.3K ﹤0.01% 6280
2024
Q3 		$119K Sell
5,300
-100
-2% -$2.31K ﹤0.01% 5053
2024
Q2 		$109K Buy
5,400
+2,100
+64% +$47.4K ﹤0.01% 5288
2024
Q1 		$82K Sell
3,300
-9,700
-75% -$206K ﹤0.01% 5783
2023
Q4 		$235K Buy
13,000
+8,500
+189% +$141K ﹤0.01% 4506
2023
Q3 		$90K Buy
4,500
+3,200
+246% +$73.2K ﹤0.01% 5192
2023
Q2 		$33K Sell
1,300
-96,500
-99% -$2.24M ﹤0.01% 6247
2023
Q1 		$2.08M Buy
97,800
+96,500
+7,423% +$2.42M ﹤0.01% 1922
2022
Q4 		$38K Buy
1,300
+1,200
+1,200% +$32.2K ﹤0.01% 6192
2022
Q3 		$2K Sell
100
-2,800
-97% -$66.6K ﹤0.01% 9230
2022
Q2 		$48K Sell
2,900
-22,900
-89% -$483K ﹤0.01% 6537
2022
Q1 		$1.13M Buy
25,800
+24,300
+1,620% +$1.13M ﹤0.01% 2762
2021
Q4 		$91K Buy
+1,500
New +$82.8K ﹤0.01% 6404

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's BCYC Position: Q1 2026 in Review

Simplex Trading sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 19,986 shares — an estimated $114K sold.

Simplex Trading first reported a position in BCYC in Q4 2021 and held it in 12 quarters. The position peaked at $1.7M in Q2 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Simplex Trading reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 19,986 Bicycle Therapeutics shares in Q1 2026, an estimated $114K.
  • Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 12 quarters.
  • Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.